{
  "id": 13089383,
  "title": "London’s Sava raises €32.08 million and partners with Ascensia to bring its glucose microsensor to Europe",
  "url": "https://urgent.news/2026/10/09/londons-sava-raises-32-08-million-and-partners-with-ascensia-to-bring",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-09T10:09:19.000Z",
  "source": {
    "name": "EU-Startups",
    "slug": "eu-startups",
    "url": "https://www.eu-startups.com/2026/10/londons-sava-raises-e32-08-million-and-partners-with-ascensia-to-bring-its-glucose-microsensor-to-europe/"
  },
  "original_language": "en",
  "account": "London-based HealthTech firm Sava Technologies has secured €32.08 million in a Series B funding round, led by Ascensia. This brings the company's total funding to $68 million. The investment will support manufacturing scale-up and commercial readiness for Sava's glucose microsensor. The partnership aims to bring this innovative technology to Europe, marking a significant advancement in diabetes care.",
  "summary": "Sava Technologies, a London-based HealthTech company developing a wearable biosensor platform that detects molecules just beneath the skin, today announced a $36 million Series B round to fund manufacturing scale-up and commercial readiness. The round was led by Ascensia, with participation from institutional investors Balderton Capital, Norrsken VC, Simplyhealth Ventures, JamJar Investments,…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}